673 related articles for article (PubMed ID: 7525636)
1. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
2. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I (IGF-I) and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization.
Barni T; Vannelli BG; Sadri R; Pupilli C; Ghiandi P; Rizzo M; Selli C; Serio M; Fiorelli G
J Clin Endocrinol Metab; 1994 Mar; 78(3):778-83. PubMed ID: 7510307
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
Cohen P; Nunn SE; Peehl DM
J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
[TBL] [Abstract][Full Text] [Related]
6. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-binding proteins in R3230AC mammary tumors of intact and diabetic rats.
Korc-Grodzicki B; Ren N; Hilf R
Endocrinology; 1993 Nov; 133(5):2362-70. PubMed ID: 7691588
[TBL] [Abstract][Full Text] [Related]
8. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
9. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries.
el-Roeiy A; Chen X; Roberts VJ; Shimasakai S; Ling N; LeRoith D; Roberts CT; Yen SS
J Clin Endocrinol Metab; 1994 Jun; 78(6):1488-96. PubMed ID: 7515389
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K; Wegmann BR; Havemann K; Jaques G
J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
[TBL] [Abstract][Full Text] [Related]
11. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation.
Price WA; Stiles AD; Moats-Staats BM; D'Ercole AJ
Endocrinology; 1992 Mar; 130(3):1424-32. PubMed ID: 1371449
[TBL] [Abstract][Full Text] [Related]
13. Reduction of insulin-like growth factor-I (IGF-I) in protein-restricted rats is associated with differential regulation of IGF-binding protein messenger ribonucleic acids in liver and kidney, and peptides in liver and serum.
Lemozy S; Pucilowska JB; Underwood LE
Endocrinology; 1994 Aug; 135(2):617-23. PubMed ID: 7518385
[TBL] [Abstract][Full Text] [Related]
14. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis.
Irwin JC; Dsupin BA; Giudice LC
J Clin Endocrinol Metab; 1995 Feb; 80(2):619-26. PubMed ID: 7531715
[TBL] [Abstract][Full Text] [Related]
15. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium.
Vollenhoven BJ; Herington AC; Healy DL
J Clin Endocrinol Metab; 1993 May; 76(5):1106-10. PubMed ID: 7684390
[TBL] [Abstract][Full Text] [Related]
16. Hormonal regulation of astroglial insulin-like growth factor (IGF)-binding protein gene expression by IGFs and insulin.
Bradshaw SL; Han VK
Endocrinology; 1993 Oct; 133(4):1767-77. PubMed ID: 7691580
[TBL] [Abstract][Full Text] [Related]
17. Development of specific antibodies to rat insulin-like growth factor-binding proteins (IGFBP-2 to -6): analysis of IGFBP production by rat granulosa cells.
Liu XJ; Malkowski M; Guo Y; Erickson GF; Shimasaki S; Ling N
Endocrinology; 1993 Mar; 132(3):1176-83. PubMed ID: 7679972
[TBL] [Abstract][Full Text] [Related]
18. Identification, localization, and regulation of insulin-like growth factor binding proteins and their messenger ribonucleic acids in the newborn rat olfactory bulb.
Russo VC; Edmondson SR; Mercuri FA; Buchanan CR; Werther GA
Endocrinology; 1994 Oct; 135(4):1437-46. PubMed ID: 7523098
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle.
Zhou J; Dsupin BA; Giudice LC; Bondy CA
J Clin Endocrinol Metab; 1994 Dec; 79(6):1723-34. PubMed ID: 7527408
[TBL] [Abstract][Full Text] [Related]
20. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
Le H; Arnold JT; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
